These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Barutta F; Bellini S; Canepa S; Durazzo M; Gruden G Acta Diabetol; 2021 Jul; 58(7):819-830. PubMed ID: 33528734 [TBL] [Abstract][Full Text] [Related]
4. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank. Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW; Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159 [TBL] [Abstract][Full Text] [Related]
5. Trajectories of kidney function in diabetes: a clinicopathological update. Oshima M; Shimizu M; Yamanouchi M; Toyama T; Hara A; Furuichi K; Wada T Nat Rev Nephrol; 2021 Nov; 17(11):740-750. PubMed ID: 34363037 [TBL] [Abstract][Full Text] [Related]
6. Hyperfiltration in Indigenous Australians with and without diabetes. Ekinci EI; Hughes JT; Chatfield MD; Lawton PD; Jones GR; Ellis AG; Cass A; Thomas M; MacIsaac RJ; O'Dea K; Jerums G; Maple-Brown LJ Nephrol Dial Transplant; 2015 Nov; 30(11):1877-84. PubMed ID: 26142395 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease. Nascimento LRD; Domingueti CP J Bras Nefrol; 2019; 41(3):412-422. PubMed ID: 30742700 [TBL] [Abstract][Full Text] [Related]
9. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate. Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y; Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827 [TBL] [Abstract][Full Text] [Related]
10. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus. Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026 [TBL] [Abstract][Full Text] [Related]
11. A study of the natural history of diabetic kidney disease (DKD). Altemtam N; Russell J; El Nahas M Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study. Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653 [TBL] [Abstract][Full Text] [Related]
13. Association of -1082A>G Polymorphism in the Interleukin-10 Gene with Estimated Glomerular Filtration Rate in Type 2 Diabetes. Polina ER; da Silva Pereira BL; Crispim D; Sbruzzi RC; Canani LH; Dos Santos KG Kidney Blood Press Res; 2017; 42(6):1164-1174. PubMed ID: 29227971 [TBL] [Abstract][Full Text] [Related]
14. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease. Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550 [TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach. Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809 [No Abstract] [Full Text] [Related]
16. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. Farah RI; Al-Sabbagh MQ; Momani MS; Albtoosh A; Arabiat M; Abdulraheem AM; Aljabiri H; Abufaraj M BMC Nephrol; 2021 Jun; 22(1):223. PubMed ID: 34134654 [TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic Risk Indicators for Kidney Disease in Mexican Patients with Type 2 Diabetes. Velázquez-López L; Hernández-Sánchez R; Roy-García I; Muñoz-Torres AV; Medina-Bravo P; Escobedo-de la Peña J Arch Med Res; 2018 Apr; 49(3):191-197. PubMed ID: 30119978 [TBL] [Abstract][Full Text] [Related]
18. Normoalbuminuric diabetic kidney disease. Chen C; Wang C; Hu C; Han Y; Zhao L; Zhu X; Xiao L; Sun L Front Med; 2017 Sep; 11(3):310-318. PubMed ID: 28721497 [TBL] [Abstract][Full Text] [Related]
19. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol. Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S; BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374 [TBL] [Abstract][Full Text] [Related]
20. Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Huang HX; Shen LL; Huang HY; Zhao LH; Xu F; Zhang DM; Zhang XL; Chen T; Wang XQ; Xie Y; Su JB Diabetes Metab J; 2021 Nov; 45(6):868-879. PubMed ID: 33752319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]